Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 3, 1999, Pages 458-464

  Pugin, Jérôme ^a   Widmer, Marie Claude ^b   Kossodo, Sylvie ^b   Liang, Chi Ming ^b   Preas II, H L ^b   Suffredini, Anthony F ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

AUTACOID; ENZYME PRECURSOR; GELATINASE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; METALLOPROTEINASE; PROGELATINASE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BACTEREMIA; BLOOD; CASE REPORT; DRUG EFFECT; ENDOTOXEMIA; ENZYMOLOGY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; MALE; NEUTROPHIL; SECRETION;

AGED; BACTEREMIA; ENDOTOXEMIA; ENZYME PRECURSORS; FEMALE; GELATINASES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; METALLOENDOPEPTIDASES; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033088484     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.3.3311     Document Type: Article

References (27)

1. Bone, R. C. 1991. Gram-negative sepsis. Chest 100:802-808.
2. Pugin, J. 1994. Bactercmia, sepsis and shock. Intensive Care Med. 20:92-93.
3. Krane, S. M. 1994. Clinical importance of metalloproteinases and their inhibitors. Ann. NY Acad. Sci. 732:1-10.
4. Goetzl, E. J., M. J. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. J. Immunol. 165:1-4.
5. Murphy, G., J. J. Reynolds, U. Bretz, and M. Baggiolini. 1982. Partial purification of collagenase and gelatinase from polymorphonuclear leucocytes: analyses of their actions on soluble and insoluble collagens. Biochem. J. 203:209-221.
6. Overall, C. M. 1994. Regulation of tissue inhibitor of metalloproteinase expression. Ann. NY Acad. Sci. 732:51-63.
7. Shah, S. V., W. H. Baricos, and A. Basci. 1987. Degradation of human glomerular basement membrane by stimulated neutrophils: activation of a melalloproteinasc(s) by reactive oxygen metabolites. J. Clin. Invest. 79:25-31.
8. Shapiro, S. D. 1994. Elastolytic mctalloproteinases produced by human mononuclear phagocytes: potential role in destructive lung disease. Am. J. Respir. Crit Care Med. 150:S160-S164.
9. Delclaux, C., C. Delacourt, M.-P. d'Ortho, V. Boyer, C. Lafuma, and A. Harf. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14:288-295.
10. Suffredini, A. F., D. Reda, S. M. Banks, M. Tropea, J. M. Agosti, and R. Miller. 1995. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J. Immunol. 155:5038-5045.
11. Hanemaaijer, R., P. Koolwijk, L. Le Clercq, W. J. A. De Vree, and V. W. M. Van Hinsbergh. 1993. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: effects of tumor necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J. 296:803-809.
12. Kjeldsen, L., A. H. Johnsen, H. Sengelov, and N. Borregaard. 1993. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268:10425-10432.
13. Dandona, P., D. Nix, M. F. Wilson, A. Aljada, J. Love, M. Assicot, and C. Bohuon. 1994. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metabol. 79:1605-1608.
14. Assicot, M., D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon. 1993. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518.
15. Snedecor, G. W., and W. G. Cochrane. 1980. Statistical Methods. Iowa State University, Ames, IA.
16. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchencko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
17. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Anna. Rev. Immunol. 13:437-457.
18. Nielsen, B. S., S. Timshel, L. Kjeldsen, M. Sehested, C. Pyke, N. Borregaard, and K. Dano. 1996. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer 65:57-62.
19. Saarialho-Kere, U. K., H. G. Welgus, and W. C. Parks. 1993. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 268:17354-17361.
20. Hibbs, M. S., K. A. Hasty, J. M. Seyer, A. H. Kang, and C. L. Mainardi. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493-2500.
21. Borregaard, N., L. Kjeldsen, K. Lollike, and H. Sengelov. 1995. Granules and secretory vesicles of the human neutrophil. Clin. Exp. Immunol. 1:6-9.
22. Sengelov, H., P. Follin, L. Kjeldsen, K. Lollike, C. Dahlgren, and N. Borregaard. 1995. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J. Immunol. 154:4157-4165.
23. Wang, D., K. M. Pabst, Y. Aida, and M. J. Pabst. 1995. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukoc. Biol. 57: 865-874.
24. Masure, S., P. Proost, J. Van Damme, and G. Opdenakker. 1991. Purification and identification of 91-kDa neutrophil gelatinase: release by the activating peptide interleukin-8. Eur. J. Biochem. 198:391-398.
25. Kaufman, S. E., J. F. Di Persio, and J. C. Gasson. 1989. Effects of human GM-CSF on neutrophil degranulation in vitro. Exp. Hematol. 17:800-804.
26. Tapper, H. 1996. The secretion of preformed granules by macrophages and neutrophils. J. Leuk. Biol. 59:613-622.
27. van Deventer, S. J. H., H. R. Buller, J. W. ten Cate, A. Sturk, and W. Pauw. 1988. Endotoxemia: an early predictor of septicaemia in febrile patients. Lancet I:605-608.